Subscribe: MedWorm: Diabetes
http://www.medworm.com/rss/medicalfeeds/conditions/Diabetes.xml
Added By: Feedage Forager Feedage Grade B rated
Language: English
Tags:
diabetes  health  insulin  medical news  medical  medscape medical  medscape  medworm  new  news  source medscape  source  study 
Rate this Feed
Rate this feedRate this feedRate this feedRate this feedRate this feed
Rate this feed 1 starRate this feed 2 starRate this feed 3 starRate this feed 4 starRate this feed 5 star

Comments (0)

Feed Details and Statistics Feed Statistics
Preview: MedWorm: Diabetes

MedWorm: Diabetes News



MedWorm.com provides a medical RSS filtering service. Thousands of medical RSS feeds are combined and output via different filters. This feed contains the latest news in Diabetes



Last Build Date: Fri, 23 Feb 2018 05:39:49 +0100

 



Irregular Shift Work Ups Risk for Type 2 Diabetes Irregular Shift Work Ups Risk for Type 2 Diabetes

Thu, 22 Feb 2018 21:48:28 +0100

People who work rotating shifts, especially those who work a lot of nights, are more likely to have type 2 diabetes than those who only work during the day or those on permanent nights.Medscape Medical News (Source: Medscape Medical News Headlines)

MedWorm Message: Have you tried our new medical search engine? More powerful than before. Log on with your social media account. 100% free.




Valeritas inks distribution deal in Italy for V-Go insulin delivery device

Thu, 22 Feb 2018 16:52:45 +0100

Valeritas (NSDQ:VLRX) has inked an exclusive distribution deal with Movi SpA for the commercialization of its V-Go wearable insulin delivery device in Italy. According to the terms of the deal, Movi will market and sell the V-Go device to diabetes clinics and patients in Italy, while Valeritas will remain responsible for the product’s development, regulatory approval and manufacturing. Get the full story at our sister site, Drug Delivery Business News. The post Valeritas inks distribution deal in Italy for V-Go insulin delivery device appeared first on MassDevice. (Source: Mass Device)



Heavy Drinking Is the Biggest Risk Factor for Dementia, Study Says

Thu, 22 Feb 2018 15:48:26 +0100

Hot on the heels of headlines linking alcohol consumption with longer life comes new research that casts a much more sobering light on drinking. According to an analysis of more than 1 million people—the largest study of its kind to date—scientists say that heavy alcohol use is the biggest modifiable risk factor for dementia, especially early-onset forms of the disease. The findings, which are published in The Lancet Public Health, came as a shock to the researchers involved. “We hypothesized that alcohol would play some role, but I don’t think anyone expected the size of the effect to be so large,” says lead author Dr. Jürgen Rehm, director of the University of Toronto’s Center for Addiction and Mental Health Institute for Mental Health Policy Rese...



Docs Question Ethics of Diabetes Drugs CV Outcomes Studies Docs Question Ethics of Diabetes Drugs CV Outcomes Studies

Thu, 22 Feb 2018 15:20:01 +0100

In a viewpoint article, two former pharma employees question the ethics of FDA-mandated studies on diabetes drugs and suggest the results shouldn't influence clinical guidelines.Medscape Medical News (Source: Medscape Medical News Headlines)



Insulet beats the Street with Q4, FY17 sales

Thu, 22 Feb 2018 14:10:00 +0100

Insulet (NSDQ:PODD) reported yesterday that the insulin delivery device-maker topped sales expectations on Wall Street for its fourth quarter and full-year financial results, but missed earnings estimates. The Billerica, Mass.-based company reeled in losses, posting -$6.9 million on sales of $130.5 million for the 3 months ended Dec. 31, for sales growth of 26% compared with the same period last year. Get the full story at our sister site, Drug Delivery Business News. The post Insulet beats the Street with Q4, FY17 sales appeared first on MassDevice. (Source: Mass Device)



Novo's pioneering diabetes pill impresses in first big study

Thu, 22 Feb 2018 12:53:00 +0100

COPENHAGEN/LONDON (Reuters) - The world's largest diabetes drugmaker, Novo Nordisk, on Thursday presented the first successful data from a large final-stage study of a pill it hopes will transform the diabetes market. (Source: Reuters: Health)

MedWorm Message: If you are looking to buy something in the January Sales please visit TheJanuarySales.com for a directory of all the best sales in the UK. Any income gained via affiliate links keeps MedWorm running.




Novo Nordisk successfully kicks off final-stage trials for first diabetes pill

Thu, 22 Feb 2018 10:46:24 +0100

COPENHAGEN (Reuters) - The world's largest diabetes drugmaker Novo Nordisk on Thursday presented the first successful data from a final-stage study for a pill it hopes will transform the diabetes market. (Source: Reuters: Health)



TSH and Risk of Sudden Cardiac Death and Total Mortality TSH and Risk of Sudden Cardiac Death and Total Mortality

Thu, 22 Feb 2018 05:14:48 +0100

A new study examines the possible relationship between TSH levels, sudden cardiac death, total mortality, and CVD outcomes.Clinical Endocrinology (Source: Medscape Today Headlines)



Perioperative Considerations Patients With T2DM on SGLT2i Perioperative Considerations Patients With T2DM on SGLT2i

Thu, 22 Feb 2018 05:14:48 +0100

SGLT2 inhibitors create new management challenges for anesthesiologists. What are the unique considerations for diabetic patients taking these agents perioperatively?Anesthesia & Analgesia (Source: Medscape Today Headlines)



Working Nights May Raise Diabetes Risk

Wed, 21 Feb 2018 20:02:19 +0100

The more often people worked nights, the more likely they were to have Type 2 diabetes. (Source: NYT Health)



Express Scripts to include Novo Nordisk ’ s once-weekly diabetes drug on 2018 formulary

Wed, 21 Feb 2018 19:37:27 +0100

Express Scripts, one of the nation’s largest pharmacy benefit managers, reportedly plans to include Novo Nordisk‘s (NYSE:NVO) once-weekly Type II diabetes, Ozempic, on its 2018 formulary. The move puts Ozempic directly in competition with Eli Lilly‘s (NYSE:LLY) once-weekly Trulicity drug. Both products will also go up against AstraZeneca‘s (NYSE:AZN) once-weekly Bydureon medication. Get the full story at our sister site, Drug Delivery Business News. The post Express Scripts to include Novo Nordisk’s once-weekly diabetes drug on 2018 formulary appeared first on MassDevice. (Source: Mass Device)

MedWorm Message: Have you tried our new medical search engine? More powerful than before. Log on with your social media account. 100% free.




Novo Nordisk gets nod from U.S. drug purchaser for new diabetes hope

Wed, 21 Feb 2018 16:59:40 +0100

COPENHAGEN (Reuters) - Insulin maker Novo Nordisk said its Ozempic diabetes drug had been included on a list of medicines approved for patients covered by U.S. private health schemes, setting the stage for a battle with Eli Lilly's Trulicity. (Source: Reuters: Health)



Medtronic Introduces MiniMed(TM) Mio(TM) Advance Infusion Set for People with Diabetes

Wed, 21 Feb 2018 15:41:06 +0100

New Infusion Set Offers Simpler, Faster, and More Convenient(1) Insulin Pump Experience DUBLIN - February 21, 2018 -- (Healthcare Sales & Marketing Network) -- Medtronic plc (NYSE:MDT), the global leader in medical technology, services and solutions, to... Devices, Drug Delivery, Product Launch Medtronic, MiniMed, Mio Advance, Infusion Set, insulin pump, diabetes (Source: HSMN NewsFeed)



SGLT2 Inhibitor-Linked Diabetic Ketoacidosis Is Rare, but Severe SGLT2 Inhibitor-Linked Diabetic Ketoacidosis Is Rare, but Severe

Wed, 21 Feb 2018 15:10:15 +0100

A series of Australian cases of DKA linked to SGLT2 inhibitors confirms the side effect is rare but severe. Most cases had identifiable precipitators.Medscape Medical News (Source: Medscape Medical News Headlines)



Medtronic expands insulin pump portfolio with MiniMed Mio infusion set

Wed, 21 Feb 2018 14:49:50 +0100

Medtronic (NYSE:MDT) has launched its MiniMed Mio Advance infusion sets, which are designed for people managing their diabetes with insulin pump therapy. The medtech titan touted its product, which was developed by ConvaTec, as boasting a user-friendly design that allows patients to access hard-to-reach sites, like the lower back. The infusion system has no visible needle and features a built-in insertion device, according to Medtronic. Get the full story at our sister site, Drug Delivery Business News. The post Medtronic expands insulin pump portfolio with MiniMed Mio infusion set appeared first on MassDevice. (Source: Mass Device)



Tandem Diabetes bids for Health Canada nod

Wed, 21 Feb 2018 14:16:19 +0100

Tandem Diabetes Care (NSDQ:TNDM) has submitted a medical device license application to Health Canada in the hopes of launching its t:slim X2 insulin pump in Canada in the second half of this year. The San Diego, Calif.-based company expects that its device will be able to display both English and French and will include a 24-hour clock. Get the full story at our sister site, Drug Delivery Business News. The post Tandem Diabetes bids for Health Canada nod appeared first on MassDevice. (Source: Mass Device)

MedWorm Message: If you are looking to buy something in the January Sales please visit TheJanuarySales.com for a directory of all the best sales in the UK. Any income gained via affiliate links keeps MedWorm running.




Senseonics ’ implantable glucose monitor succeeds in 90-day trial

Wed, 21 Feb 2018 13:45:19 +0100

A 90-day trial involving patients with Type I and Type II diabetes showed that Senseonics‘ (NYSE:SENS) implantable continuous glucose monitor was safe and accurate compared to reference glucose values, according to a study published in Diabetes Technology & Therapeutics. The single-arm study enrolled 90 participants and implanted them with Senseonics’ Eversense device, which sends glucose data every five minutes to a transmitter. The transmitter then communicates that data to a mobile app, which displays the values in real-time. The system also includes alarms to warn the user if they’re approaching hyper- or hypoglycemia. Get the full story at our sister site, Drug Delivery Business News. The post Senseonics’ implantable glucose monitor succeeds in 90-day trial a...



Diabetes - these five pence a day supplements could LOWER blood sugar

Wed, 21 Feb 2018 13:12:51 +0100

DIABETES type 2 symptoms can include feeling very thirsty, being very tired, or unexplained weight loss. But, you could lower your blood sugar by adding these supplements to your diet everyday, it ’s been revealed. (Source: Daily Express - Health)



Wearable technology could aid condition monitoring

Wed, 21 Feb 2018 11:30:00 +0100

Patients with long-term conditions, such as diabetes, could one day benefit from new types of sensor technology that are being developed by UK researchers. (Source: Nursing Times)



Rotating Night Shifts a Path to Diabetes, Study Suggests

Wed, 21 Feb 2018 07:00:00 +0100

Title: Rotating Night Shifts a Path to Diabetes, Study SuggestsCategory: Health NewsCreated: 2/20/2018 12:00:00 AMLast Editorial Review: 2/21/2018 12:00:00 AM (Source: MedicineNet Diabetes General)



UNIST introduces new smart contact lens for diabetics

Wed, 21 Feb 2018 05:00:00 +0100

(Ulsan National Institute of Science and Technology(UNIST)) A team of researchers, affiliated with South Korea's Ulsan National Institute of Science and Technology (UNIST) has succeeded in developing a new biosensing contact lens capable of detecting glucose levels in patients with diabetes. (Source: EurekAlert! - Biology)

MedWorm Message: Have you tried our new medical search engine? More powerful than before. Log on with your social media account. 100% free.




Touchstone Center provides insight into glucagon's role in diabetic heart disease

Wed, 21 Feb 2018 05:00:00 +0100

(UT Southwestern Medical Center) A UT Southwestern study reveals the hormone glucagon's importance to the development of insulin resistance and cardiac dysfunction during Type 2 diabetes, presenting opportunities to develop new therapies for diabetic diseases of the heart muscle. (Source: EurekAlert! - Medicine and Health)



Cracking the connection between pediatric obesity and cancer

Wed, 21 Feb 2018 01:08:45 +0100

Obesity and cancer risk have a mysterious relationship, with obesity increasing the risk for 13 types of cancer. For some cancers — including pediatric cancers — obesity affects survival rates, which are lower for people who are obese.With an increasing population of overweight and obese children in the United States, researchers and physicians are racing to understand this connection – and what to do about it.Dr.Steven Mittelman, chief of pediatric endocrinology atUCLA Mattel Children ’s Hospital, is among those looking for clues to improve children ’s survival and recovery from cancer. But unlike most other researchers, Mittelman explores the connection from the perspective of the fat cell, not the cancer cell; he’s trying to understand the environment in the body that fat it...



Rotating Night Shifts a Path to Diabetes

Tue, 20 Feb 2018 22:15:11 +0100

The more often a person worked an irregular night shift, the greater their risk for type 2 diabetes, the findings showed. (Source: WebMD Health)



Roche ’s Accu-Chek diabetes management app receives its fifth FDA recall

Tue, 20 Feb 2018 20:55:55 +0100

Roche ’s Accu-Chek Connect Diabetes Management App has hit yet another snag with the FDA. On February 15, the agency issued a Class 2 Device Recall for certain software versions of the app due to a bug that could lead users to self-administer inappropriate doses of insulin. (Source: mobihealthnews)



DarioHealth launches Dario blood glucose monitor on Amazon

Tue, 20 Feb 2018 20:45:26 +0100

DarioHealth (NSDQ:DRIO) said today it launched its Dario blood glucose monitoring system on the Amazon marketplace, touting that the system has already been sold through the site. The company’s blood glucose monitor, which syncs with Dario’s diabetes management app, connects via a headphone jack to a mobile device, helping diabetes patients monitor their blood glucose throughout the day. The app also records carbohydrate intake, insulin use and physical activity. Read the whole story on our sister site, Drug Delivery Business The post DarioHealth launches Dario blood glucose monitor on Amazon appeared first on MassDevice. (Source: Mass Device)

MedWorm Message: If you are looking to buy something in the January Sales please visit TheJanuarySales.com for a directory of all the best sales in the UK. Any income gained via affiliate links keeps MedWorm running.




UPDATE: Robotics delay pushes Medtronic down despite fiscal Q3 beats

Tue, 20 Feb 2018 19:30:13 +0100

Medtronic (NYSE:MDT) shares took a hit today after the world’s largest medical device maker said its robot-assisted surgery platform has fallen behind schedule, despite fiscal third-quarter results that topped the consensus forecast on Wall Street. Fridley, Minn.-based Medtronic had predicted first-in-human cases during the fiscal year ending in April, with a full launch following in fiscal 2019. But during a conference call with investors today discussing the Q3 numbers, chairman & CEO Omar Ishrak said the timetable has gotten longer. “We are enthusiastic about the development of our surgical robotics platform, which we expect will strengthen our strategy of advancing minimally invasive procedures and we continue to make progress towards its launch. While we had intended f...






Can Alcohol Help You Live Longer? Here ’s What the Research Really Says

Tue, 20 Feb 2018 18:48:00 +0100

New research, which was presented at the American Association for the Advancement of Science’s annual conference, has found that moderate drinking is linked to a longer life. Drinking about two glasses of wine or beer a day was linked to an 18% drop in a person’s risk of early death—an even stronger effect than the life-preserving practice of exercise, according to the researchers. The results came from the 90+ Study, a research project out of the University of California Irvine’s Institute for Memory Impairments and Neurological Disorders that examines the habits of people who live to at least 90. Though the study has not yet been published in a scientific journal, it triggered a spate of booze-praising headlines. But can alcohol actually help you live longer? Res...



Diabetes type 2: FIVE complications of high blood sugar if it isn't looked after

Tue, 20 Feb 2018 18:01:41 +0100

DIABETES type 2 symptoms include feeling very thirsty, unexplained weight loss and feeling very tired. This is why you should always take care to control your blood sugar. (Source: Daily Express - Health)



The Associations Between Sugar-Sweetened Beverage Consumption and Children's Health: An Updated Review of the Literature

Tue, 20 Feb 2018 17:50:58 +0100

Review examines the evidence on: 1) the health impacts of sugary beverages on children's health (obesity, diabetes risk, dental caries, and caffeine-related effects); 2) the health impact of substituting SSBs with other drinks; and 3) the role of taste preferences in SSB consumption patterns. (Source: PHPartners.org)

MedWorm Message: Have you tried our new medical search engine? More powerful than before. Log on with your social media account. 100% free.




First Documented Case of Transgender Woman Breastfeeding First Documented Case of Transgender Woman Breastfeeding

Tue, 20 Feb 2018 17:10:27 +0100

A transgender woman has fed her infant solely with breast milk for the first 6 weeks, after treatment with domperidone, estradiol, progesterone, and breast pumping.Medscape Medical News (Source: Medscape Medical News Headlines)



Medical News Today: Type 1 diabetes: Does the gut hold the key to prevention?

Tue, 20 Feb 2018 17:00:00 +0100

Researchers suggest that targeting the gut microbiota could be a potential strategy for the prevention and treatment of type 1 diabetes. (Source: Health News from Medical News Today)



It's a Draw! Low-Fat or Low-Carb Diets Equally Good, Finds Study It's a Draw! Low-Fat or Low-Carb Diets Equally Good, Finds Study

Tue, 20 Feb 2018 16:10:15 +0100

A healthy low-fat or healthy low-carb diet did not'fit'a person better, or lead to greater 1-year weight loss if it'matched'their genotype pattern or insulin secretion, contrary to preliminary studies.Medscape Medical News (Source: Medscape Internal Medicine Headlines)



Rotating Night Shifts a Path to Diabetes, Study Suggests

Tue, 20 Feb 2018 16:02:18 +0100

TUESDAY, Feb. 20, 2018 -- Working the night shift may play havoc with your blood sugar levels, a new study contends. For the study, researchers looked at data on more than 270,000 people in the United Kingdom and found that those who worked... (Source: Drugs.com - Daily MedNews)



Eversense Implanted CGM Accurate for 90 Days in Diabetes Eversense Implanted CGM Accurate for 90 Days in Diabetes

Tue, 20 Feb 2018 14:13:00 +0100

Novel device under FDA review, could improve CGM adherence in diabetes.Medscape Medical News (Source: Medscape Medical News Headlines)

MedWorm Message: If you are looking to buy something in the January Sales please visit TheJanuarySales.com for a directory of all the best sales in the UK. Any income gained via affiliate links keeps MedWorm running.




Leveraging genomics to illuminate race/ethnicity differences in type 2 diabetes

Tue, 20 Feb 2018 12:28:48 +0100

February 22, 2018 3:00-4:00pm ET. (Source: PHPartners.org)



Viral hormones have potential to cause diabetes in humans

Tue, 20 Feb 2018 12:00:00 +0100

According to a study inPNAS, scientists have identified four viruses that produce insulin-like peptides capable of stimulating human cells. Science Daily (Source: Society for Endocrinology)



Bariatric surgery more likely to stop taking diabetes drugs

Tue, 20 Feb 2018 12:00:00 +0100

A new study published inJAMA Surgery suggests that obese patients who undergo bariatric surgery are more likely to stop taking diabetes medication. Medical Xpress (Source: Society for Endocrinology)



Diabetes and obesity: How you can survive and thrive

Tue, 20 Feb 2018 11:48:54 +0100

(Natural News) Diabetes and obesity: These diseases now affect tens of millions of people worldwide. Their global prevalence has been on the rise since the ‘80s and shows little sign of slowing down. Sadly, far from just impacting the lives of adults and the elderly, diabetes and obesity have spread to the youth as well.... (Source: NaturalNews.com)



Uganda:NSSF Offers Free Yellow Fever Vaccination During Customer Week

Tue, 20 Feb 2018 07:44:37 +0100

[Observer] National Social Security Fund (NSSF) has today kicked off its annual Customer Connect week with various activities including a medical camp that will see Ugandans get free Hepatitis B, diabetes and blood pressure screening and Yellow fever vaccination. (Source: AllAfrica News: Health and Medicine)

MedWorm Message: Have you tried our new medical search engine? More powerful than before. Log on with your social media account. 100% free.




Sedentary Behaviors and Cardiometabolic Risk Sedentary Behaviors and Cardiometabolic Risk

Tue, 20 Feb 2018 06:14:47 +0100

It's well accepted that TV viewing and other sedentary behaviors are associated with cardiometabolic risk. Does replacing TV viewing with a different sedentary behavior impact risk level?American Journal of Epidemiology (Source: Medscape Today Headlines)



Weight Gain After Treatment of Graves' Disease in Children Weight Gain After Treatment of Graves' Disease in Children

Tue, 20 Feb 2018 06:14:47 +0100

Which children are more susceptible to weight gain after treatment for Graves'disease?Clinical Endocrinology (Source: Medscape Today Headlines)



HealthWatch: Drinking Soda May Impact Fertility

Mon, 19 Feb 2018 22:42:06 +0100

BOSTON (CBS) — Could drinking soda affect your chances of having a baby? Researchers at the Boston University School of Public Health surveyed almost 5,000 men and women and found that drinking one or more sugar-sweetened beverages a day, by either partner, male or female, was associated with a 20% lower chance of getting pregnant each month. Prior studies have found that drinking soda can lead to poor semen quality, as well as obesity and type two diabetes which also can impact fertility. The researchers found little impact from drinking fruit juices or diet soda, but they say that couples who want to get pregnant might want to consider reducing their intake of sugary drinks. (Source: WBZ-TV - Breaking News, Weather and Sports for Boston, Worcester and New Hampshire)



Diabetes could be triggered by virus, scientists warn

Mon, 19 Feb 2018 20:24:58 +0100

Harvard University scientists found that four viruses contain insulin-like proteins. The new research suggests that these may trigger type 1 and type 2 diabetes by tricking the body. (Source: the Mail online | Health)



Toxic stress and protective factors in multi-ethnic school age children: a research protocol - Condon EM, Sadler LS, Mayes LC.

Mon, 19 Feb 2018 18:03:30 +0100

Exposure to stressful environments in early childhood can cause a toxic stress response and lead to poor health outcomes, including obesity, cardiac disease, diabetes, and mental illness. In animals and maltreated children, the presence of a nurturing care... (Source: SafetyLit)

MedWorm Message: If you are looking to buy something in the January Sales please visit TheJanuarySales.com for a directory of all the best sales in the UK. Any income gained via affiliate links keeps MedWorm running.




The risks of sarcopenia, falls and fractures in patients with type 2 diabetes mellitus - Sarodnik C, Bours SPG, Schaper NC, van den Bergh JP, van Geel TACM.

Mon, 19 Feb 2018 18:03:30 +0100

Fracture risk in patients with type 2 diabetes mellitus (T2DM) is increased, and the mechanism is multifactorial. Recent research on T2DM-induced bone fragility shows that bone mineral density (BMD) is often normal or even slightly elevated. However, bone ... (Source: SafetyLit)



CABG Best for Diabetics with Multivessel CAD, Low LVEF

Mon, 19 Feb 2018 18:00:00 +0100

(MedPage Today) -- Long-term survival reduced with PCI (Source: MedPage Today Cardiovascular)



Ketogenic Drinks Improve Glycemia and Insulin Sensitivity Ketogenic Drinks Improve Glycemia and Insulin Sensitivity

Mon, 19 Feb 2018 15:37:33 +0100

A small trial in healthy volunteers hints at a possible role for'keto drinks'in metabolic disorders.Medscape Medical News (Source: Medscape Medical News Headlines)



Acetaminophen Use Alters Sex Hormones, May Cause Birth Defects? Acetaminophen Use Alters Sex Hormones, May Cause Birth Defects?

Mon, 19 Feb 2018 14:23:52 +0100

Metabolomics study identifies'unexpected effects of a commonly used drug, acetaminophen, on hormone metabolism. Closer scrutiny of this commonly used medication is warranted. 'Medscape Medical News (Source: Medscape Medical News Headlines)



Diabetes type 2 - REVERSE high blood sugar by following this diet plan

Mon, 19 Feb 2018 14:15:00 +0100

DIABETES type 2 symptoms include fatigue, frequent urination and loss of muscle bulk. You could reverse the high blood sugar condition by making these diet swaps. (Source: Daily Express - Health)

MedWorm Message: Have you tried our new medical search engine? More powerful than before. Log on with your social media account. 100% free.




Persistent Glucose Disorders After Control of Acromegaly Persistent Glucose Disorders After Control of Acromegaly

Mon, 19 Feb 2018 05:21:10 +0100

Patients with acromegaly may be at continued risk for glucose disorders -- even after hypersecretion of growth hormone has been controlled.Journal of the Endocrine Society (Source: Medscape Today Headlines)



Physical exercise reduces risk of developing diabetes -- study

Mon, 19 Feb 2018 05:00:00 +0100

(University of Birmingham) Exercising more reduces the risk of diabetes and could see seven million fewer diabetic patients across mainland China, Hong Kong and Taiwan, according to new research. (Source: EurekAlert! - Medicine and Health)



Insulin goes viral

Mon, 19 Feb 2018 05:00:00 +0100

(Joslin Diabetes Center) Scientists at Joslin Diabetes Center have identified four viruses that can produce insulin-like hormones that are active on human cells. The discovery brings new possibilities for revealing biological mechanisms that may cause diabetes or cancer. (Source: EurekAlert! - Cancer)



Type 1 diabetes trial reaches full enrollment

Mon, 19 Feb 2018 05:00:00 +0100

(Sanford Health/Sanford Research) A clinical trial studying type 1 diabetes has reached full enrollment. The Sanford Project: T-Rex Study, a Phase 2 clinical trial conducted collaboratively by Sanford Health and Caladrius Biosciences, Inc., (Caladrius)(Nasdaq: CLBS), has completed enrollment of 110 children with type 1 diabetes. The study started with two sites at Sanford Health in Sioux Falls, South Dakota, and Fargo, North Dakota, and expanded to 13 additional sites across the United States. (Source: EurekAlert! - Medicine and Health)



Scientists create first human-sheep hybrids

Sun, 18 Feb 2018 00:35:32 +0100

The successful Stanford University project could even open the door to finding a cure for type 1 diabetes by creating healthy pancreases to regulate blood sugar. (Source: the Mail online | Health)

MedWorm Message: If you are looking to buy something in the January Sales please visit TheJanuarySales.com for a directory of all the best sales in the UK. Any income gained via affiliate links keeps MedWorm running.




Using Art to Tackle Diabetes in Youth

Sat, 17 Feb 2018 19:47:30 +0100

The Bigger Picture campaign uses spoken-word poems and music videos to highlight how Type 2 diabetes impacts communities. (Source: NYT Health)



Valeritas Presents Data Demonstrating V-Go & #194; & #174; Wearable Insulin Delivery Device ...

Fri, 16 Feb 2018 19:02:52 +0100

BRIDGEWATER, N.J., Feb. 15, 2018 - Valeritas Holdings, Inc. (NASDAQ:VLRX), a medical technology company which offers patients with type 2 diabetes V-Go® Wearable Insulin Delivery device, a simple, affordable, all-in-one insulin delivery option that is worn like a patch and can eliminate the need for taking multiple daily shots, announced today it presented positive findings from its MOTIV4CONTROL study as a poster at The 11th International Conference on Advanced Technologies&...This story is related to the following:Medical Devices (Source: Industrial Newsroom - Health, Medical and Dental Supplies)



New UN high-profile panel set to take on noncommunicable diseases, cause of seven in 10 deaths globally

Fri, 16 Feb 2018 17:24:31 +0100

Bold, innovative solutions are now on the table to accelerate the prevention and control of deadly noncommunicable diseases (NCDs) – such as heart and lung disease, cancers and diabetes – as a new United Nations health agency high-level commission gets set to begin its work. (Source: UN News Centre - Health, Poverty, Food Security)



Medical News Today: Common blood pressure drug may prevent type 1 diabetes

Fri, 16 Feb 2018 17:00:00 +0100

Researchers reveal that methyldopa — a drug commonly used to lower blood pressure — could also be used for the prevention and treatment of type 1 diabetes. (Source: Health News from Medical News Today)



FDA issues warning for Roche ’ s Accu-Chek diabetes management app

Fri, 16 Feb 2018 15:35:34 +0100

The FDA today issued a Class 2 device recall for Roche‘s (OTC:RHHBY) Accu-Chek connected diabetes management app. The company first notified the regulatory agency of the software bug in June last year. Roche reported that certain iOS and Andriod versions of the app had a program error in the Bolus Advisor feature – a calculator that helps the user determine insulin doses based on data from a glucose meter. Get the full story at our sister site, Drug Delivery Business News. The post FDA issues warning for Roche’s Accu-Chek diabetes management app appeared first on MassDevice. (Source: Mass Device)

MedWorm Message: Have you tried our new medical search engine? More powerful than before. Log on with your social media account. 100% free.




Africa:World Leaders Join New Drive to Beat Noncommunicable Diseases

Fri, 16 Feb 2018 15:34:47 +0100

[WHO] Geneva -WHO is announcing today a new high-level commission, comprised of heads of state and ministers, leaders in health and development and entrepreneurs. The group will propose bold and innovative solutions to accelerate prevention and control of the leading killers on the planet -- noncommunicable diseases (NCDs) like heart and lung disease, cancers, and diabetes. (Source: AllAfrica News: Health and Medicine)



FDA Okays Glooko Insulin Dosing System for Type 2 Diabetes FDA Okays Glooko Insulin Dosing System for Type 2 Diabetes

Fri, 16 Feb 2018 15:11:55 +0100

New app allows clinicians to personalize insulin dose titration for patients and reminds them to follow instructions.Medscape Medical News (Source: Medscape Medical News Headlines)



Tandem inks distribution deal in Scandinavia for insulin pumps

Fri, 16 Feb 2018 13:33:33 +0100

Tandem Diabetes Care (NSDQ:TNDM) has inked a distribution agreement with Rubin Medical to commercialize the medical device company’s t:slim X2 insulin pump, insulin cartridges and t:lock infusion sets in Sweden, Norway and Denmark. According to the terms of the deal, Rubin Medical is slated to perform all sales, marketing and customer training for Tandem’s devices. Get the full story at our sister site, Drug Delivery Business News. The post Tandem inks distribution deal in Scandinavia for insulin pumps appeared first on MassDevice. (Source: Mass Device)



FT Health: Lessons from the Oxfam scandal

Fri, 16 Feb 2018 12:42:37 +0100

UK chief for Pasteur Institute, cognitive prosthetics, fighting diabetes via hip hop (Source: FT.com - Drugs and Healthcare)



Bariatric surgery more successful for glycaemic control in diabetes

Fri, 16 Feb 2018 12:00:00 +0100

According to a study, published in Bariatric Surgical Practice and Patient Care, bariatric surgery is more successful than abdominoplasty for improving glycemic control in patients with type 2 diabetes.Healio  (Source: Society for Endocrinology)

MedWorm Message: If you are looking to buy something in the January Sales please visit TheJanuarySales.com for a directory of all the best sales in the UK. Any income gained via affiliate links keeps MedWorm running.




World leaders join new drive to beat noncommunicable diseases

Fri, 16 Feb 2018 11:00:00 +0100

WHO is announcing today a new high-level commission, comprised of heads of state and ministers, leaders in health and development and entrepreneurs. The group will propose bold and innovative solutions to accelerate prevention and control of the leading killers on the planet – noncommunicable diseases (NCDs) like heart and lung disease, cancers, and diabetes. The WHO Independent Global High-level Commission on NCDs is co-chaired by President Tabar é Vázquez of Uruguay; President Maithripala Sirisena of Sri Lanka; President Sauli Niinistö of Finland; Veronika Skvortsova, Minister of Healthcare of the Russian Federation; and Sania Nishtar, former Federal Minister of Pakistan. (Source: WHO news)



Cameroon:Blindness, Diabetic Retinopathy - Women Mostly Affected!

Fri, 16 Feb 2018 10:47:46 +0100

[Cameroon Tribune] This is one of the results of an investigation carried out in Yaounde by an international NGO, "Sightsavers and Partners." (Source: AllAfrica News: Health and Medicine)



Estradiol Therapy Mitigates Effects of Stress on Memory Estradiol Therapy Mitigates Effects of Stress on Memory

Fri, 16 Feb 2018 05:15:15 +0100

A new study examines how postmenopausal estradiol therapy may impact the effects of stress on cognition.Journal of Clinical Endocrinology & Metabolism (Source: Medscape Today Headlines)



Service dogs: Should I get one if I have diabetes?

Fri, 16 Feb 2018 00:00:00 +0100

(Source: MayoClinic.com - Ask a Specialist)



Two Long-acting GLP-1 Agonists Have Differing Efficacy, Tolerability Two Long-acting GLP-1 Agonists Have Differing Efficacy, Tolerability

Thu, 15 Feb 2018 21:47:00 +0100

Results of an open-label study provide more evidence of variability in efficacy and tolerability of agents in the long-acting glucagon-like peptide-1 receptor (GLP-1R) agonist class of diabetes medicines.Reuters Health Information (Source: Medscape Medical News Headlines)

MedWorm Message: Have you tried our new medical search engine? More powerful than before. Log on with your social media account. 100% free.




Digital health news briefs for 2/15/2018

Thu, 15 Feb 2018 21:05:32 +0100

Insulin dose tool gains CE Mark.  DreaMed Diabetes has received a CE Mark for its Type 1-focused clinical decision support (CDS) platform, Advisor Pro. The tool’s algorithms process data from a number of connected diabetes management devices to provide a personalized insulin dosing treatment plan. (Source: mobihealthnews)



Tandem Diabetes touts pivotal study of insulin pump with low glucose suspend feature

Thu, 15 Feb 2018 19:23:47 +0100

Tandem Diabetes Care (NSDQ:TNDM) touted data today from a pivotal study of its t:slim X2 insulin pump, which features a predictive low glucose suspend feature called Basal-IQ. The study showed that the system reduced time spent in hypoglycemia by 31% compared to just sensor-augmented pump therapy, according to Tandem. Get the full story at our sister site, Drug Delivery Business News. The post Tandem Diabetes touts pivotal study of insulin pump with low glucose suspend feature appeared first on MassDevice. (Source: Mass Device)



Diabetes type 2 diet - avoid this popular breakfast item to manage symptoms of condition

Thu, 15 Feb 2018 17:01:48 +0100

DIABETES is a condition that causes a person ’s blood sugar level to become too high. As well as doing regular exercise and carrying out blood tests to make sure blood glucose levels stay balanced it’s important to eat the right things. Avoiding a particular breakfast item will help, according to one expert. (Source: Daily Express - Health)



Medtronic looks to expand MiniMed 670G into pediatric diabetes

Thu, 15 Feb 2018 16:51:47 +0100

Medtronic (NYSE:MDT) touted data today from an at-home pediatric study of its MiniMed 670G hybrid closed-loop diabetes management system. The company’s study included 105 kids, ages 7 to 13, and found that patients spent more time in the target blood glucose range, had less glycemic variability and experienced less hypo- and hyperglycemia compared to baseline data. Data from the pediatric study was included as part of an application to the FDA, as Medtronic looks to expand MiniMed’s indication to include children between the ages of 7 and 13. Get the full story at our sister site, Drug Delivery Business News. The post Medtronic looks to expand MiniMed 670G into pediatric diabetes appeared first on MassDevice. (Source: Mass Device)



Alcohol Advice Demands Full Disclosure First Alcohol Advice Demands Full Disclosure First

Thu, 15 Feb 2018 16:06:32 +0100

What do you tell patients who ask about'safe'alcohol intake--or who inquire about your own drinking habits?Medscape Diabetes & Endocrinology (Source: Medscape Today Headlines)

MedWorm Message: If you are looking to buy something in the January Sales please visit TheJanuarySales.com for a directory of all the best sales in the UK. Any income gained via affiliate links keeps MedWorm running.




DreaMed Diabetes wins CE Mark for insulin therapy management platform

Thu, 15 Feb 2018 13:39:15 +0100

DreaMed Diabetes has won CE Mark clearance for its Advisor Pro decision-support platform, designed to help healthcare professionals manage insulin therapy for their Type I diabetes patients. The company’s cloud-based platform provides personalized insulin treatment plans by combining data from insulin pumps and continuous glucose monitors. Using machine learning techniques, the system analyzes all of the data it collects from connected devices to come up with an optimized insulin dosing treatment plan. Get the full story at our sister site, Drug Delivery Business News. The post DreaMed Diabetes wins CE Mark for insulin therapy management platform appeared first on MassDevice. (Source: Mass Device)



You Asked: Do Religious People Live Longer?

Thu, 15 Feb 2018 13:15:10 +0100

If a long life is what you’re after, going to church may be the answer to your prayers. A number of studies have shown associations between attending religious services and living a long time. One of the most comprehensive, published in JAMA Internal Medicine in 2016, found that women who went to any kind of religious service more than once a week had a 33% lower chance than their secular peers of dying during the 16-year study-follow-up period. Another study, published last year in PLOS One, found that regular service attendance was linked to reductions in the body’s stress responses and even in mortality–so much so that worshippers were 55% less likely to die during the up to 18-year follow-up period than people who didn’t frequent the temple, church or mosque. Y...



Amish People Stay Healthy in Old Age. Here ’s Their Secret

Thu, 15 Feb 2018 13:15:10 +0100

Many people think of the Amish as living without. These devout communities, predominantly located in Pennsylvania, Ohio and Indiana, go without cars, TVs, computers, phones or even the electricity needed to run so much of 21st century gadgetry. But what researchers who have studied them have found is what the Amish have a surplus of: good health in late life. The average American life expectancy is currently just under 79 years. Back in 1900, it was only 47, but for early–20th century Amish it was already greater than 70. Over the decades, most Americans have caught up in overall life expectancy, but the Amish still have a significant edge in late-life health, with lower rates of cancer, cardiovascular disease, diabetes and more. So how do they do it? Start with lifestyle. Amish com...



Increasing intake of folate found to reduce risk of developing type-2 diabetes in women

Thu, 15 Feb 2018 10:41:47 +0100

(Natural News) Recent findings of Korean scientists suggest that increasing folate intake could help protect women against type-2 diabetes, as concluded in a Diabetes.co.uk article. Also known as Vitamin B9 folic acid (when taken as a synthetic supplement), folate is an essential vitamin involved in the creation of healthy proteins, DNA, and cell division. As it cannot... (Source: NaturalNews.com)



Here's to a Healthy Pregnancy

Thu, 15 Feb 2018 09:02:15 +0100

THURSDAY, Feb. 15, 2018 -- Take good prenatal care of yourself and not only will you have a healthier baby, you'll also lower his or her risk of type 2 diabetes, obesity and heart disease later in life. First, you'll want to monitor your weight... (Source: Drugs.com - Daily MedNews)

MedWorm Message: Have you tried our new medical search engine? More powerful than before. Log on with your social media account. 100% free.




Researchers find existing drug effective at preventing onset of type 1 diabetes

Thu, 15 Feb 2018 09:00:00 +0100

A drug commonly used to control high blood pressure may also help prevent the onset of type 1 diabetes in up to 60 percent of those at risk for the disease, according to researchers at the University of Colorado Anschutz Medical Campus and the University of Florida in Gainesville. The study was published online this week in the Journal of Clinical Investigation. (Source: World Pharma News)



Rates of Incident Diabetes and Prediabetes in Treated HIV Rates of Incident Diabetes and Prediabetes in Treated HIV

Thu, 15 Feb 2018 05:14:52 +0100

A new study sheds light on the incidence of diabetes and prediabetes among men with long-term treated HIV infection.AIDS (Source: Medscape Today Headlines)



Co-occurrence of Testosterone Deficiency and Body Fatness Co-occurrence of Testosterone Deficiency and Body Fatness

Thu, 15 Feb 2018 05:14:52 +0100

A combination of low testosterone and obesity may increase the risk of mortality among men, a new study reports.Clinical Endocrinology (Source: Medscape Today Headlines)



Efforts are needed to help pregnant women with diabetes

Thu, 15 Feb 2018 05:00:00 +0100

(Wiley) Researchers who analyzed data from the UK's National Pregnancy in Diabetes Audit found concerning shortcomings in pregnancy preparation and prenatal care for women with diabetes. In addition, significant clinic-to-clinic variation across the England and Wales suggests opportunities for improvement. (Source: EurekAlert! - Medicine and Health)



Researchers find existing drug effective at preventing onset of type 1 diabetes

Thu, 15 Feb 2018 05:00:00 +0100

(University of Colorado Anschutz Medical Campus) A drug commonly used to control high blood pressure may also help prevent the onset of type 1 diabetes in up to 60 percent of those at risk for the disease, according to researchers at the University of Colorado Anschutz Medical Campus and the University of Florida in Gainesville. (Source: EurekAlert! - Medicine and Health)

MedWorm Message: If you are looking to buy something in the January Sales please visit TheJanuarySales.com for a directory of all the best sales in the UK. Any income gained via affiliate links keeps MedWorm running.




Diabetes type 2 - the BEST exercise to lower your blood sugar

Thu, 15 Feb 2018 04:00:00 +0100

DIABETES type 2 symptoms include passing more urine than usual, unexplained weight loss and having an unquenchable thirst. But, you could lower your blood sugar by doing this exercise. (Source: Daily Express - Health)



Eating More Slowly Can Help Weight Loss Eating More Slowly Can Help Weight Loss

Wed, 14 Feb 2018 20:55:22 +0100

Eating more slowly, along with not eating within 2 hours of going to sleep, and cutting out after dinner snacks, could help with weight loss, researchers say.WebMD Health News (Source: Medscape Medical News Headlines)



Anti-VEGF Agents Improve Vision Despite Ongoing Diabetic Macular Edema Anti-VEGF Agents Improve Vision Despite Ongoing Diabetic Macular Edema

Wed, 14 Feb 2018 19:52:43 +0100

In patients with diabetic macular edema (DME), aflibercept and ranibizumab are more effective than bevacizumab in preventing disease persistence, but each drug can lead to substantial gains in vision, according to a post hoc analysis of a randomized trial.Reuters Health Information (Source: Medscape Diabetes Headlines)



Sanofi touts real-world data for Toujeo insulin glargine injection

Wed, 14 Feb 2018 19:08:53 +0100

Sanofi (NYSE:SNY) touted data today from its 10,000-patient Lightning study, which evaluated electronic medical records of adults with Type II diabetes to study its long-acting insulin glargine injection, Toujeo. The company found that Toujeo significantly lowered patients’ risk of experiencing severe low blood sugar compared to other long-acting insulin, like its own Lantus product. Get the full story at our sister site, Drug Delivery Business News. The post Sanofi touts real-world data for Toujeo insulin glargine injection appeared first on MassDevice. (Source: Mass Device)



Could Money Spent on Diabetes Medications Pay for Surgery? Could Money Spent on Diabetes Medications Pay for Surgery?

Wed, 14 Feb 2018 18:13:45 +0100

Those with obesity are more likely to stop taking glucose-lowering medication for diabetes 6 years after bariatric surgery than controls. Could money earmarked for drugs be redirected to pay for operations?Medscape Medical News (Source: Medscape Medical News Headlines)

MedWorm Message: Have you tried our new medical search engine? More powerful than before. Log on with your social media account. 100% free.




Medicine Teams With Young Artists to Shift Diabetes Message Medicine Teams With Young Artists to Shift Diabetes Message

Wed, 14 Feb 2018 16:43:03 +0100

Video poems aim to show teenagers the systemic reasons type 2 diabetes has infiltrated their families and hope to ignite their social justice energy to reverse the disease trajectory.Medscape Medical News (Source: Medscape Internal Medicine Headlines)



This smartphone case monitors blood glucose on the go

Wed, 14 Feb 2018 16:39:54 +0100

[Image from David Baillot/UC San Diego Jacobs School of Engineering]University of California San Diego engineers have created a smartphone case that, when paired with an app, can make it easier for people with diabetes to track and record blood glucose levels on the go. “Integrating blood glucose sensing into a smartphone would eliminate the need for patients to carry a separate device,” Patrick Mercier, professor of electrical and computer engineering at UC San Diego, said in a press release. “An added benefit is the ability to autonomously store, process and send blood glucose readings from the phone to a care provider or cloud service.” Get the full story on our sister site, Medical Design & Outsourcing. The post This smartphone case monitors blood glucose on the go appeared...



Phase II Data Support Potential for Novel Anti-VEGF/Anti-Angiopoietin-2 Bispecific Antibody, RG7716, for People With Diabetic Macular Edema

Wed, 14 Feb 2018 16:15:06 +0100

RG7716 is the first bispecific antibody designed specifically for the treatment of retinal eye diseases RG7716 demonstrated clinically meaningful and statistically significant improvements in visual acuity Key secondary and exploratory anatomical out... Biopharmaceuticals, Ophthalmology Genentech, Roche Group, diabetic macular edema, Anti-VEGF, Anti-Angiopoietin-2 (Source: HSMN NewsFeed)



Using Art to Tackle Obesity and Diabetes in Youth

Wed, 14 Feb 2018 16:06:40 +0100

The Bigger Picture campaign uses spoken-word poems and music videos to highlight how Type 2 diabetes impacts communities. (Source: NYT Health)



Tandem closes $69m underwritten public offering

Wed, 14 Feb 2018 16:04:59 +0100

Tandem Diabetes Care (NSDQ:TNDM) has closed its previously-announced underwritten public offering of 30 million shares of common stock at $2.00 apiece. The San Diego, Calif.-based company reeled in $69 million from the offering, after underwriters exercised an option to buy 4.5 million additional shares of Tandem’s common stock. Get the full story at our sister site, Drug Delivery Business News. The post Tandem closes $69m underwritten public offering appeared first on MassDevice. (Source: Mass Device)

MedWorm Message: If you are looking to buy something in the January Sales please visit TheJanuarySales.com for a directory of all the best sales in the UK. Any income gained via affiliate links keeps MedWorm running.




Glooko receives FDA clearance for mobile insulin titration tool

Wed, 14 Feb 2018 15:55:02 +0100

Digital diabetes care company Glooko announced today that its Mobile Insulin Dosing System (MIDS) — an app-driven tool that recommends insulin dose adjustments using data collected directly from a patient’s blood glucose meter — has been cleared by the FDA. (Source: mobihealthnews)



Bariatric Surgery Enabled Stopping Diabetes Meds (CME/CE)

Wed, 14 Feb 2018 15:00:00 +0100

(MedPage Today) -- In French study, nearly half of obese patients with diabetes discontinued medications after surgery (Source: MedPage Today Cardiovascular)



Glooko wins FDA nod for mobile insulin dosing system

Wed, 14 Feb 2018 14:32:37 +0100

The FDA has approved Glooko‘s mobile insulin dosing system, which is designed to titrate long-acting insulin for people with Type II diabetes. The company’s system accesses blood glucose data directly from the user’s glucose meter so that the user doesn’t have to manually enter their fasting glucose values. Then, it analyzes those levels to recommend insulin dose adjustments based on a healthcare provider’s treatment plan and published clinical guidelines. Get the full story at our sister site, Drug Delivery Business News. The post Glooko wins FDA nod for mobile insulin dosing system appeared first on MassDevice. (Source: Mass Device)



Mallinckrodt Enrolls First Patient in Phase 1 Study of ExpressGraft(TM)C9T1 Skin Tissue

Wed, 14 Feb 2018 12:57:32 +0100

Study of Genetically Engineered Human Skin Substitute to Assess Safety and Tolerability in the Treatment of Diabetic Foot Ulcers STAINES-UPON-THAMES, United Kingdom, Feb. 14, 2018 -- (Healthcare Sales & Marketing Network) -- Mallinckrodt plc (NYSE: MNK... Devices, Wound Care Mallinckrodt plc, ExpressGraft-C9T1, diabetic foot ulcers (Source: HSMN NewsFeed)